semaglutide cardiovascular outcomes study 2025 news Beyond obesity: Novo's SELECT re-defines risk management Phase 3 Trial of Semaglutide

"Yes, that's why our abstract title asks, 'Too much of a good thing?' When I'm talking to patients about going on these drugs, they're like, 'I don't want to go on another medicine.' I say, 'You know what

Because these medications act on the digestive system, its not surprising that many of the side effects are related to digestion

7 In patients who meet these criteria, the ADA preferably recommends use of a GLP-1 RA with proven cardiovascular benefit or an SGLT-2 inhibitor with proven cardiovascular benefit provided they have adequate kidney function

Compounded semaglutide may not have the same quality control measures, which could lead to variations in the drugs strength and purity

What youll learn: Rybelsus, made with semaglutide, is the only GLP-1 pill approved for diabetes management